Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-alpha in patients with metastatic renal cell carcinoma Article

cited authors

  • Garcia, Jorge A.; Mekhail, Tarek; Elson, Paul; Wood, Laura; Bukowski, Ronald M.; Dreicer, Robert; Rini, Brian I.

authors

Publication Date

  • January 1, 2012

webpage

published in

category

keywords

  • II
  • granulocyte-macrophage colony-stimulating factor
  • immunotherapy
  • interferon-a2b
  • interleukin-2
  • phase I
  • renal cell carcinoma

start page

  • 63

end page

  • 69

volume

  • 109

issue

  • 1